(NewsNation) — Mammogram providers are now federally required to tell their patients about their breast density, which not only increases the risk of cancer but makes it harder to detect.
The new U.S. Food and Drug Administration standards for the procedure were first released in March 2023, with an implementation deadline of Sept. 9, 2024.
According to the FDA, around half of women 40 or older in the United States have dense breast tissue.
"Dense breast tissue...